Lowenfeld, L., Zaheer, S., Oechsle, C., Fracol, M., Datta, J., Xu, S., . . . Czerniecki, B. J. (2016). Addition of anti-estrogen therapy to anti-HER2 dendritic cell vaccination improves regional nodal immune response and pathologic complete response rate in patients with ER(pos)/HER2(pos) early breast cancer. Oncoimmunology.
Chicago Style CitationLowenfeld, Lea, et al. "Addition of Anti-estrogen Therapy to Anti-HER2 Dendritic Cell Vaccination Improves Regional Nodal Immune Response and Pathologic Complete Response Rate in Patients With ER(pos)/HER2(pos) Early Breast Cancer." Oncoimmunology 2016.
Cita MLALowenfeld, Lea, et al. "Addition of Anti-estrogen Therapy to Anti-HER2 Dendritic Cell Vaccination Improves Regional Nodal Immune Response and Pathologic Complete Response Rate in Patients With ER(pos)/HER2(pos) Early Breast Cancer." Oncoimmunology 2016.